Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets − sarcoma treatment in progress-Reference-Cited by-同舟云学术

Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets − sarcoma treatment in progress

Published:2011-11 Issue:2 Volume:20 Page:185-193
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Krukemeyer Manfred Georg,Krenn Veit,Jakobs Martin,Wagner Wolfgang

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference21 articles.

1. Magnetic Drug Targeting—Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment

2. Magnetisches Drug Targeting—ein neuer Ansatz in der lokoregionären Tumortherapie mit Chemotherapeutika

3. Targeting cancer cells: magnetic nanoparticles as drug carriers

4. Medical Applications of Magnetic Nanoparticles

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response;International Journal of Molecular Sciences;2024-02-28

2. In Vitro Studies of Pegylated Magnetite Nanoparticles in a Cellular Model of Viral Oncogenesis: Initial Studies to Evaluate Their Potential as a Future Theranostic Tool;Pharmaceutics;2023-02-01

3. Drug Conjugation Chemistry in Iron Oxide Nanoparticles (IONPs);Nanomedicine and Nanotoxicology;2023

4. The emerging role of cancer nanotechnology in the panorama of sarcoma;Frontiers in Bioengineering and Biotechnology;2022-10-17

5. Strongylopus grayii tadpole blastema extract exerts cytotoxic effects on embryonal rhabdomyosarcoma cells;In Vitro Cellular & Developmental Biology - Animal;2022-08-10